Sinopharm Says Second Covid Vaccine Found to Be Safe

The second vaccine developed by Sinopharm has been found to be safe and able to generate high titers of antibodies among participants in phase I and II clinical trials, according to a Weibo posting by Sinopharm Group on Sunday.

©2020 Bloomberg L.P.

BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.